Prostate Cancer - Results from #23100

Transrectal saturation technique may improve cancer detection as an initial prostate biopsy strategy in men with prostate-specific antigen July 29, 2013

Repetitively dosed docetaxel and (153)samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer - Abstract July 29, 2013

FDA Drug Safety Communication: FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems July 29, 2013

Comparing dosimetric, morbidity, quality of life, and cancer control outcomes after 3D conformal, intensity-modulated, and proton radiation therapy for prostate cancer - Abstract July 29, 2013

Hypofractionation for clinically localized prostate cancer - Abstract July 29, 2013

Management of prostate cancer in elderly men - Abstract July 29, 2013

Takeda announces unblinding of phase 3 study of orteronel in patients with metastatic, castration-resistant prostate cancer that progressed post-chemotherapy based on interim analysis July 27, 2013

Adjuvant versus salvage radiotherapy for high-risk prostate cancer patients - Abstract July 27, 2013

Cancer control and complications of salvage local therapy after failure of radiotherapy for prostate cancer: A systematic review - Abstract July 27, 2013

Diagnostic performance of initial transperineal template-guided mapping biopsy of the prostate gland - Abstract July 27, 2013

Impact of international variation of prostate cancer on a predictive nomogram for biochemical recurrence in clinically localised prostate cancer - Abstract July 27, 2013

Treatment of early-stage prostate cancer among rural and urban patients - Abstract July 27, 2013

A literature review of cost-effectiveness analyses of prostate-specific antigen test in prostate cancer screening - Abstract July 26, 2013

Multidisciplinary care and management selection in prostate cancer - Abstract July 26, 2013

Prognostic factors for newly diagnosed prostate cancer and their role in treatment selection - Abstract July 26, 2013

How can I help myself? A critical review of modifiable behaviors, medications, and complementary alternative medicine for men receiving radiotherapy for prostate cancer - Abstract July 26, 2013

Picking the optimal duration of hormonal therapy in men with high-risk and locally advanced prostate cancer treated with radiotherapy - Abstract July 26, 2013

Immunotherapy: A therapeutic revolution against prostate cancer? - Abstract July 26, 2013

Intermediate-risk prostate cancer patients treated with androgen deprivation therapy and a hypofractionated radiation regimen with or without image guided radiotherapy - Abstract July 26, 2013

Focal therapy for prostate cancer: Rationale and treatment opportunities - Abstract July 26, 2013

Page 1156 of 1458